louisiana tirzepatide class action Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues Compounded Tirzepatide Weight Loss Program

With the market arrival of oral Wegovy and Orforglipron , the risk for Stevanato appears evident: If patients transition to oral GLP-1 formulations, Stevanato will see a decline in orders for its subcutaneous injection packaging solutions

Chronic use of the laxative may lead to melanosis coli, which is identified by hyperpigmentation and brownish discoloration of colonic mucosa

Side Effects and Safety Profile 8.1 Overview of Tolerability Cephavet is generally well tolerated in veterinary patients

Investment banking firm Harrison Co anticipates the total addressable market for fitness clubs will increase by $6.8bn in the US alone, as a result of more people taking GLP-1s